Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19.

Authors:
Yang Y; Shen C; Li J; Yuan J; Wei J and 20 more

Journal:
J Allergy Clin Immunol

Publication Year: 2020

DOI:
10.1016/j.jaci.2020.04.027

PMCID:
PMC7189843

PMID:
32360286

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Allergy Clin Immunol

Abbreviation: J Allergy Clin Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Autoimmunity and immunodeficiency associated with monoallelic LIG4 mutations via haploinsufficiency.
Jauch AJ; Bignucolo O; Seki S and 34 more (2023) - Transparency Score: 3/6
Development of mouse models with restricted HLA-B∗57:01 presentation for the study of flucloxacilli…
Ananthula S; Krishnaveni Sivakumar K; Cardone M and 6 more (2023) - Transparency Score: 3/6
Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inf…
LeSuer WE; Kienzl M; Ochkur SI and 7 more (2023) - Transparency Score: 4/6
Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and m…
Bucciol G; COVID Human Genetic Effort; Meyts I. (2023) - Transparency Score: 3/6
Phospholipid remodeling and its derivatives are associated with COVID-19 severity.
Wei J; Liu X; Xiao W and 13 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest."

Evidence found in paper:

"This study was supported by the 10.13039/501100001809National Natural Science Foundation of China (grant nos. 81802004 and 81788101), 10.13039/100007225Ministry of Science and Technology (grant no. 2020YFC0846300), the National Science and Technology Major Project (grant nos. 2018ZX10711001, 2017ZX10204401, and 2017ZX10103011), Shenzhen Science and Technology Research and Development Project (grant nos. JCYJ20180228162201541 and 202002073000001), 10.13039/501100012151Sanming Project of Medicine in Shenzhen (grant no. SZSM201512005), and the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (grant no. 2017-I2M-1-009)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025